Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of key m5C modification-related genes in type 2 diabetes. | Front Genet | 2022 | 36276976 | PubTator, text mining | PubMed |
| Role of mitochondria-associated endoplasmic reticulum membranes in insulin sensitivity, energy metabolism, and contraction of skeletal muscle. | Front Mol Biosci | 2022 | 36275635 | PubTator, text mining | PubMed |
| Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. | Cancer Commun (Lond) | 2022 | 36266736 | PubTator, text mining | PubMed |
| Time-restricted feeding mitigates obesity through adipocyte thermogenesis. | Science | 2022 | 36264811 | PubTator, text mining | PubMed |
| The effect of long non-coding RNAs in joint destruction of rheumatoid arthritis. | Front Cell Dev Biol | 2022 | 36263019 | PubTator, text mining | PubMed |
| Pyruvate dehydrogenase kinase 4 promotes ubiquitin-proteasome system-dependent muscle atrophy. | J Cachexia Sarcopenia Muscle | 2022 | 36259412 | PubTator, text mining | PubMed |
| Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats. | Clin Sci (Lond) | 2022 | 36259366 | PubTator, text mining | PubMed |
| The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma. | Front Oncol | 2022 | 36249029 | PubTator, text mining | PubMed |
| Complement membrane attack complex is an immunometabolic regulator of NLRP3 activation and IL-18 secretion in human macrophages. | Front Immunol | 2022 | 36248901 | PubTator, text mining | PubMed |
| Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device. | Front Cardiovasc Med | 2022 | 36247468 | PubTator, text mining | PubMed |
| The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus. | Int J Mol Sci | 2022 | 36232910 | PubTator, text mining | PubMed |
| Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. | Int J Mol Sci | 2022 | 36232796 | PubTator, text mining | PubMed |
| On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping. | Int J Mol Sci | 2022 | 36232732 | PubTator, text mining | PubMed |
| Visceral Adipose Tissue Molecular Networks and Regulatory microRNA in Pediatric Obesity: An In Silico Approach. | Int J Mol Sci | 2022 | 36232337 | PubTator, text mining | PubMed |
| Visceral Adipose Tissue E2F1-miRNA206/210 Pathway Associates with Type 2 Diabetes in Humans with Extreme Obesity. | Cells | 2022 | 36231008 | PubTator, text mining | PubMed |
| Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs. | Cells | 2022 | 36230935 | PubTator, text mining | PubMed |
| Early Mechanisms of Chemoresistance in Retinoblastoma. | Cancers (Basel) | 2022 | 36230889 | PubTator, text mining | PubMed |
| Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer. | Cancer Cell Int | 2022 | 36229828 | PubTator, text mining | PubMed |
| Single-cell sequencing of PBMC characterizes the altered transcriptomic landscape of classical monocytes in BNT162b2-induced myocarditis. | Front Immunol | 2022 | 36225942 | PubTator, text mining | PubMed |
| Fibronectin-1 is a dominant mechanism for rheumatoid arthritis via the mediation of synovial fibroblasts activity. | Front Cell Dev Biol | 2022 | 36225320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=37